Business Description
Cytogen Inc
ISIN : KR7217330000
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | -2.02 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.37 | |||||
Beneish M-Score | -2.7 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 93.8 | |||||
3-Year EBITDA Growth Rate | -41.5 | |||||
3-Year EPS without NRI Growth Rate | -23.5 | |||||
3-Year FCF Growth Rate | -25.3 | |||||
3-Year Book Growth Rate | 30.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.37 | |||||
9-Day RSI | 19.5 | |||||
14-Day RSI | 25.6 | |||||
6-1 Month Momentum % | -15.61 | |||||
12-1 Month Momentum % | -28.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 18.32 | |||||
Quick Ratio | 18.32 | |||||
Days Inventory | 18.87 | |||||
Days Sales Outstanding | 64.41 | |||||
Days Payable | 31.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.5 | |||||
Shareholder Yield % | 4.97 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.54 | |||||
Operating Margin % | -255.48 | |||||
Net Margin % | -452.01 | |||||
FCF Margin % | -312.54 | |||||
ROE % | -56.25 | |||||
ROA % | -29.53 | |||||
ROIC % | -16.53 | |||||
ROC (Joel Greenblatt) % | -68.02 | |||||
ROCE % | -30.76 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 54.7 | |||||
PB Ratio | 3.62 | |||||
Price-to-Tangible-Book | 3.62 | |||||
EV-to-EBIT | -16.74 | |||||
EV-to-EBITDA | -19.49 | |||||
EV-to-Revenue | 51.8 | |||||
EV-to-FCF | -16.57 | |||||
Price-to-Net-Current-Asset-Value | 5.47 | |||||
Earnings Yield (Greenblatt) % | -5.97 | |||||
FCF Yield % | -4.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cytogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 3,268.687 | ||
EPS (TTM) (â‚©) | -774.131 | ||
Beta | -0.06 | ||
Volatility % | 23.94 | ||
14-Day RSI | 25.6 | ||
14-Day ATR (â‚©) | 718.16996 | ||
20-Day SMA (â‚©) | 11466.5 | ||
12-1 Month Momentum % | -28.87 | ||
52-Week Range (â‚©) | 9200 - 19330 | ||
Shares Outstanding (Mil) | 22.22 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cytogen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cytogen Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Cytogen Inc Frequently Asked Questions
What is Cytogen Inc(XKRX:217330)'s stock price today?
When is next earnings date of Cytogen Inc(XKRX:217330)?
Does Cytogen Inc(XKRX:217330) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |